{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:21:32Z","timestamp":1793157692823,"version":"4.5.0"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T00:00:00Z","timestamp":1771718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T00:00:00Z","timestamp":1771718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s15010-026-02754-6","type":"journal-article","created":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T14:26:25Z","timestamp":1771770385000},"page":"1173-1190","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Human infections caused by pathogenic Burkholderia: current clinical challenges and future perspectives"],"prefix":"10.1007","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8541-7304","authenticated-orcid":false,"given":"Helal F.","family":"Hetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zinab","family":"Alatawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8025-5454","authenticated-orcid":false,"given":"Salwa Q.","family":"Bukhari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisham Ibrahim M.","family":"Barnawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelazeem M.","family":"Algammal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El-Sayed Hemdan","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4992-9589","authenticated-orcid":false,"given":"Mohammad","family":"Al Masri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7374-9334","authenticated-orcid":false,"given":"Yasmin N.","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,22]]},"reference":[{"key":"2754_CR1","first-page":"848","volume-title":"The prokaryotes: proteobacteria: alpha and beta subclasses","author":"DE Woods","year":"2006","unstructured":"Woods DE, Sokol PA, et al. The genus Burkholderia. In: Dworkin M, et al., editors. The prokaryotes: proteobacteria: alpha and beta subclasses. New York: Springer; 2006. p. 848\u201360."},{"key":"2754_CR2","unstructured":"Burkholder WH. Sour skin, a bacterial rot of onion bulbs. 1950."},{"key":"2754_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1146\/annurev.micro.112408.134030","volume":"64","author":"EE Galyov","year":"2010","unstructured":"Galyov EE, Brett PJ, DeShazer D. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Annu Rev Microbiol. 2010;64:495\u2013517.","journal-title":"Annu Rev Microbiol"},{"key":"2754_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/bmb\/ldr007","volume":"99","author":"D Limmathurotsakul","year":"2011","unstructured":"Limmathurotsakul D, Peacock SJ. Melioidosis: a clinical overview. Br Med Bull. 2011;99:125\u201339.","journal-title":"Br Med Bull"},{"issue":"2","key":"2754_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1128\/CMR.18.2.383-416.2005","volume":"18","author":"AC Cheng","year":"2005","unstructured":"Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev. 2005;18(2):383\u2013416.","journal-title":"Clin Microbiol Rev"},{"key":"2754_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/v13071331","author":"P Lauman","year":"2021","unstructured":"Lauman P, Dennis JJ. Advances in phage therapy: targeting the Burkholderia cepacia complex. Viruses. 2021. https:\/\/doi.org\/10.3390\/v13071331.","journal-title":"Viruses"},{"issue":"7","key":"2754_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1469-0691.2010.03237.x","volume":"16","author":"P Drevinek","year":"2010","unstructured":"Drevinek P, Mahenthiralingam E. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin Microbiol Infect. 2010;16(7):821\u201330.","journal-title":"Clin Microbiol Infect"},{"key":"2754_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00139-19","author":"M Tavares","year":"2020","unstructured":"Tavares M, et al. Burkholderia cepacia complex bacteria: a feared contamination risk in water-based pharmaceutical products. Clin Microbiol Rev. 2020. https:\/\/doi.org\/10.1128\/cmr.00139-19.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"2754_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13256-020-02415-8","volume":"14","author":"T Bharara","year":"2020","unstructured":"Bharara T, et al. Investigation of Burkholderia cepacia complex bacteremia outbreak in a neonatal intensive care unit: a case series. J Med Case Rep. 2020;14(1):76.","journal-title":"J Med Case Rep"},{"issue":"2","key":"2754_CR10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1365-2958.2011.07937.x","volume":"83","author":"K Agnoli","year":"2012","unstructured":"Agnoli K, et al. Exposing the third chromosome of Burkholderia cepacia complex strains as a virulence plasmid. Mol Microbiol. 2012;83(2):362\u201378.","journal-title":"Mol Microbiol"},{"issue":"12","key":"2754_CR11","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1128\/JCM.01636-16","volume":"54","author":"P Hemarajata","year":"2016","unstructured":"Hemarajata P, et al. Burkholderia pseudomallei: challenges for the clinical microbiology laboratory. J Clin Microbiol. 2016;54(12):2866\u201373.","journal-title":"J Clin Microbiol"},{"issue":"7","key":"2754_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00424-21","volume":"59","author":"I Gassiep","year":"2021","unstructured":"Gassiep I, et al. Laboratory safety: handling Burkholderia pseudomallei isolates without a biosafety cabinet. J Clin Microbiol. 2021;59(7):e0042421.","journal-title":"J Clin Microbiol"},{"key":"2754_CR13","unstructured":"Expert ASM subject matter. Sentinel level clinical laboratory guidelines for suspected agents of bioterrorism and emerging infectious diseases."},{"key":"2754_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.drup.2016.07.003","volume":"28","author":"KA Rhodes","year":"2016","unstructured":"Rhodes KA, Schweizer HP. Antibiotic resistance in Burkholderia species. Drug Resist Updat. 2016;28:82\u201390.","journal-title":"Drug Resist Updat"},{"key":"2754_CR15","unstructured":"Nguyen HN, Smith ME, Hayoun MA. Glanders and Melioidosis. In StatPearls. 2024, StatPearls Publishing Copyright\u00a9 2024, StatPearls Publishing LLC.: Treasure Island (FL) ineligible companies. Disclosure: Matthew Smith declares no relevant financial relationships with ineligible companies. Disclosure: Michael Hayoun declares no relevant financial relationships with ineligible companies."},{"issue":"12","key":"2754_CR16","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/j.1348-0421.1992.tb02129.x","volume":"36","author":"E Yabuuchi","year":"1992","unstructured":"Yabuuchi E, et al. Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol Immunol. 1992;36(12):1251\u201375.","journal-title":"Microbiol Immunol"},{"issue":"11","key":"2754_CR17","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/j.1348-0421.1995.tb03275.x","volume":"39","author":"E Yabuuchi","year":"1995","unstructured":"Yabuuchi E, et al. Transfer of two Burkholderia and an Alcaligenes species to Ralstonia gen. Nov.: proposal of Ralstonia pickettii (Ralston, Palleroni and Doudoroff 1973) comb. Nov., Ralstonia solanacearum (Smith 1896) comb. Nov. and Ralstonia eutropha (Davis 1969) comb. Nov. Microbiol Immunol. 1995;39(11):897\u2013904.","journal-title":"Microbiol Immunol"},{"issue":"1","key":"2754_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011006","volume":"17","author":"A Paauw","year":"2023","unstructured":"Paauw A, et al. Expression of virulence and antimicrobial related proteins in Burkholderia mallei and Burkholderia pseudomallei. PLoS Negl Trop Dis. 2023;17(1):e0011006.","journal-title":"PLoS Negl Trop Dis"},{"key":"2754_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/1471-2180-12-229","volume":"12","author":"A Karger","year":"2012","unstructured":"Karger A, et al. Rapid identification of Burkholderia mallei and Burkholderia pseudomallei by intact cell matrix-assisted laser desorption\/ionisation mass spectrometric typing. BMC Microbiol. 2012;12:229.","journal-title":"BMC Microbiol"},{"issue":"7","key":"2754_CR20","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3201\/eid1107.041290","volume":"11","author":"GP Gerrits","year":"2005","unstructured":"Gerrits GP, et al. Burkholderia fungorum septicemia. Emerg Infect Dis. 2005;11(7):1115\u20137.","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"2754_CR21","doi-asserted-by":"publisher","first-page":"9975","DOI":"10.3390\/molecules19079975","volume":"19","author":"Z Cui","year":"2014","unstructured":"Cui Z, et al. Susceptibility of opportunistic Burkholderia glumae to copper surfaces following wet or dry surface contact. Molecules. 2014;19(7):9975\u201385.","journal-title":"Molecules"},{"issue":"3","key":"2754_CR22","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1128\/mr.60.3.539-574.1996","volume":"60","author":"JR Govan","year":"1996","unstructured":"Govan JR, Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev. 1996;60(3):539\u201374.","journal-title":"Microbiol Rev"},{"issue":"6","key":"2754_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1099\/00222615-45-6-395","volume":"45","author":"JR Govan","year":"1996","unstructured":"Govan JR, Hughes JE, Vandamme P. Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol. 1996;45(6):395\u2013407.","journal-title":"J Med Microbiol"},{"issue":"4","key":"2754_CR24","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1099\/00207713-47-4-1188","volume":"47","author":"P Vandamme","year":"1997","unstructured":"Vandamme P, et al. Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol. 1997;47(4):1188\u2013200.","journal-title":"Int J Syst Bacteriol"},{"issue":"1","key":"2754_CR25","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ygeno.2021.11.011","volume":"114","author":"E Bach","year":"2022","unstructured":"Bach E, et al. Pangenome inventory of Burkholderia sensu lato, Burkholderia sensu stricto, and the Burkholderia cepacia complex reveals the uniqueness of Burkholderia catarinensis. Genomics. 2022;114(1):398\u2013408.","journal-title":"Genomics"},{"issue":"1","key":"2754_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-019-0306-0","volume":"18","author":"NK Devanga Ragupathi","year":"2019","unstructured":"Devanga Ragupathi NK, Veeraraghavan B. Accurate identification and epidemiological characterization of Burkholderia cepacia complex: an update. Ann Clin Microbiol Antimicrob. 2019;18(1):7.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2754_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9010051","author":"MY Wong","year":"2020","unstructured":"Wong MY, et al. Comparison of microbiological characteristics and genetic diversity between Burkholderia cepacia complex isolates from vascular access and other clinical infections. Microorganisms. 2020. https:\/\/doi.org\/10.3390\/microorganisms9010051.","journal-title":"Microorganisms"},{"key":"2754_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00273","volume":"9","author":"AA Hassan","year":"2019","unstructured":"Hassan AA, Coutinho CP, S\u00e1-Correia I. Burkholderia cepacia complex species differ in the frequency of variation of the lipopolysaccharide O-antigen expression during cystic fibrosis chronic respiratory infection. Front Cell Infect Microbiol. 2019;9:273.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2754_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00253-010-2528-0","volume":"87","author":"JH Leit\u00e3o","year":"2010","unstructured":"Leit\u00e3o JH, et al. Pathogenicity, virulence factors, and strategies to fight against Burkholderia cepacia complex pathogens and related species. Appl Microbiol Biotechnol. 2010;87(1):31\u201340.","journal-title":"Appl Microbiol Biotechnol"},{"key":"2754_CR30","unstructured":"Tille P. Bailey & Scott\u2019s diagnostic microbiology-E-Book. 2015;Elsevier Health Sciences."},{"issue":"4","key":"2754_CR31","first-page":"201","volume":"9","author":"AD Vinion-Dubiel","year":"2003","unstructured":"Vinion-Dubiel AD, Goldberg JB. Lipopolysaccharide of Burkholderia cepacia complex. J Endotoxin Res. 2003;9(4):201\u201313.","journal-title":"J Endotoxin Res"},{"issue":"39","key":"2754_CR32","doi-asserted-by":"publisher","first-page":"14246","DOI":"10.1073\/pnas.0403306101","volume":"101","author":"WC Nierman","year":"2004","unstructured":"Nierman WC, et al. Structural flexibility in the Burkholderia mallei genome. Proc Natl Acad Sci USA. 2004;101(39):14246\u201351.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Pt 5","key":"2754_CR33","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1099\/jmm.0.007724-0","volume":"58","author":"GC Whitlock","year":"2009","unstructured":"Whitlock GC, et al. Burkholderia mallei cellular interactions in a respiratory cell model. J Med Microbiol. 2009;58(Pt 5):554\u201362.","journal-title":"J Med Microbiol"},{"key":"2754_CR34","unstructured":"Bacteria, V.b.i.a.i. Burkholderia pseudomallei. 2023 (1 Juli 2025). https:\/\/www.vetbact.org\/?artid=49."},{"issue":"8","key":"2754_CR35","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/ismej.2013.36","volume":"7","author":"AM Sass","year":"2013","unstructured":"Sass AM, et al. The unexpected discovery of a novel low-oxygen-activated locus for the anoxic persistence of Burkholderia cenocepacia. Isme J. 2013;7(8):1568\u201381.","journal-title":"Isme J"},{"key":"2754_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.701362","volume":"11","author":"I Syed","year":"2021","unstructured":"Syed I, Wooten RM. Interactions between pathogenic Burkholderia and the complement system: a review of potential immune evasion mechanisms. Front Cell Infect Microbiol. 2021;11:701362.","journal-title":"Front Cell Infect Microbiol"},{"key":"2754_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.1056723","volume":"9","author":"V Mariappan","year":"2022","unstructured":"Mariappan V, et al. One Health surveillance approaches for melioidosis and glanders: the Malaysian perspective. Front Vet Sci. 2022;9:1056723.","journal-title":"Front Vet Sci"},{"key":"2754_CR38","unstructured":"American Society for Microbiology (ASM). Sentinel level clinical laboratory guidelines for suspected agents of bioterrorism and emerging infectious diseases. 2016 (1 Juli 2025). https:\/\/asm.org\/asm\/media\/policy-and-advocacy\/lrn\/sentinel%20files\/burkholderia-marc2016.pdf."},{"issue":"5","key":"2754_CR39","first-page":"442","volume":"16","author":"A Berbudi","year":"2020","unstructured":"Berbudi A, et al. Type 2 diabetes and its impact on the immune system. Curr Diabetes Rev. 2020;16(5):442\u20139.","journal-title":"Curr Diabetes Rev"},{"issue":"3","key":"2754_CR40","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s40121-023-00768-3","volume":"12","author":"W Zheng","year":"2023","unstructured":"Zheng W, et al. Risk factors for melioidosis mortality and epidemics: a multicentre, 10-year retrospective cohort study in northern Hainan. Infect Dis Ther. 2023;12(3):951\u201364.","journal-title":"Infect Dis Ther"},{"issue":"12","key":"2754_CR41","doi-asserted-by":"publisher","first-page":"e33283","DOI":"10.1016\/j.heliyon.2024.e33283","volume":"10","author":"S Kumari","year":"2024","unstructured":"Kumari S, et al. Are Burkholderia emerging pathogens in patients with underlying morbidity: a case series. Heliyon. 2024;10(12):e33283.","journal-title":"Heliyon"},{"key":"2754_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11020149","author":"S Chowdhury","year":"2022","unstructured":"Chowdhury S, et al. The epidemiology of melioidosis and its association with diabetes mellitus: a systematic review and meta-analysis. Pathogens. 2022. https:\/\/doi.org\/10.3390\/pathogens11020149.","journal-title":"Pathogens"},{"key":"2754_CR43","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00006-19","author":"I Gassiep","year":"2020","unstructured":"Gassiep I, Armstrong M, Norton R. Human melioidosis. Clin Microbiol Rev. 2020. https:\/\/doi.org\/10.1128\/CMR.00006-19.","journal-title":"Clin Microbiol Rev"},{"key":"2754_CR44","doi-asserted-by":"publisher","first-page":"17107","DOI":"10.1038\/nrdp.2017.107","volume":"4","author":"WJ Wiersinga","year":"2018","unstructured":"Wiersinga WJ, et al. Melioidosis. Nat Rev Dis Primers. 2018;4:17107.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"2754_CR45","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1067\/mpd.2002.127665","volume":"141","author":"NM Walsh","year":"2002","unstructured":"Walsh NM, et al. Risk factors for Burkholderia cepacia complex colonization and infection among patients with cystic fibrosis. J Pediatr. 2002;141(4):512\u20137.","journal-title":"J Pediatr"},{"key":"2754_CR46","doi-asserted-by":"publisher","first-page":"e55","DOI":"10.2741\/937","volume":"8","author":"T Coenye","year":"2003","unstructured":"Coenye T, LiPuma JJ. Molecular epidemiology of Burkholderia species. Front Biosci. 2003;8:e55-67.","journal-title":"Front Biosci"},{"key":"2754_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1750-1172-8-131","volume":"8","author":"KE Van Zandt","year":"2013","unstructured":"Van Zandt KE, Greer MT, Gelhaus HC. Glanders: an overview of infection in humans. Orphanet J Rare Dis. 2013;8:131.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"2754_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0013160","volume":"19","author":"AG Torres","year":"2025","unstructured":"Torres AG. Glanders: an ancient and emergent disease with no vaccine or treatment on site. PLoS Negl Trop Dis. 2025;19(6):e0013160.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"2754_CR49","volume":"2013","author":"JP Jakupciak","year":"2013","unstructured":"Jakupciak JP, et al. Population-sequencing as a biomarker of Burkholderia mallei and Burkholderia pseudomallei evolution through microbial forensic analysis. J Nucleic Acids. 2013;2013(1):801505.","journal-title":"J Nucleic Acids"},{"key":"2754_CR50","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00388-13","author":"EP Price","year":"2013","unstructured":"Price EP, et al. Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection. MBio. 2013. https:\/\/doi.org\/10.1128\/mBio.00388-13.","journal-title":"MBio"},{"key":"2754_CR51","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/gbe\/evq003","volume":"2","author":"L Losada","year":"2010","unstructured":"Losada L, et al. Continuing evolution of Burkholderia mallei through genome reduction and large-scale rearrangements. Genome Biol Evol. 2010;2:102\u201316.","journal-title":"Genome Biol Evol"},{"issue":"5","key":"2754_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000922","volume":"6","author":"H Song","year":"2010","unstructured":"Song H, et al. The early stage of bacterial genome-reductive evolution in the host. PLoS Pathog. 2010;6(5):e1000922.","journal-title":"PLoS Pathog"},{"issue":"5","key":"2754_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126437","volume":"10","author":"SM Zimmerman","year":"2015","unstructured":"Zimmerman SM, et al. The autotransporter BpaB contributes to the virulence of Burkholderia mallei in an aerosol model of infection. PLoS ONE. 2015;10(5):e0126437.","journal-title":"PLoS ONE"},{"issue":"7","key":"2754_CR54","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1128\/IAI.01939-05","volume":"74","author":"WJ Ribot","year":"2006","unstructured":"Ribot WJ, Ulrich RL. The animal pathogen-like type III secretion system is required for the intracellular survival of Burkholderia mallei within J774.2 macrophages. Infect Immun. 2006;74(7):4349\u201353.","journal-title":"Infect Immun"},{"issue":"2","key":"2754_CR55","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.cell.2015.02.044","volume":"161","author":"EL Benanti","year":"2015","unstructured":"Benanti EL, Nguyen CM, Welch MD. Virulent Burkholderia species mimic host actin polymerases to drive actin-based motility. Cell. 2015;161(2):348\u201360.","journal-title":"Cell"},{"issue":"22","key":"2754_CR56","doi-asserted-by":"publisher","first-page":"7857","DOI":"10.1128\/JB.187.22.7857-7862.2005","volume":"187","author":"JM Stevens","year":"2005","unstructured":"Stevens JM, et al. Actin-binding proteins from Burkholderia mallei and Burkholderia thailandensis can functionally compensate for the actin-based motility defect of a Burkholderia pseudomallei bimA mutant. J Bacteriol. 2005;187(22):7857\u201362.","journal-title":"J Bacteriol"},{"issue":"3","key":"2754_CR57","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/QCO.0000000000000362","volume":"30","author":"KU Saikh","year":"2017","unstructured":"Saikh KU, Mott TM. Innate immune response to Burkholderia mallei. Curr Opin Infect Dis. 2017;30(3):297\u2013302.","journal-title":"Curr Opin Infect Dis"},{"issue":"2","key":"2754_CR58","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1365-2958.2006.05519.x","volume":"63","author":"PJ Brett","year":"2007","unstructured":"Brett PJ, et al. Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes. Mol Microbiol. 2007;63(2):379\u201390.","journal-title":"Mol Microbiol"},{"key":"2754_CR59","unstructured":"Government of Canada. Burkholderia mallei: Infectious substances Pathogen Safety Data Sheet. 2023 (1 March 2025). https:\/\/www.canada.ca\/en\/public-health\/services\/laboratory-biosafety-biosecurity\/pathogen-safety-data-sheets-risk-assessment\/burkholderia-mallei.html."},{"key":"2754_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11102597","author":"EB Gaspar","year":"2023","unstructured":"Gaspar EB, et al. Assessment of the virulence of the Burkholderia mallei strain BAC 86\/19 in BALB\/c mice. Microorganisms. 2023. https:\/\/doi.org\/10.3390\/microorganisms11102597.","journal-title":"Microorganisms"},{"key":"2754_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-03071-1","volume-title":"Defense against biological attacks","author":"SK Singh","year":"2019","unstructured":"Singh SK, Kuhn JH. Defense against biological attacks. Springer; 2019."},{"issue":"11","key":"2754_CR62","doi-asserted-by":"publisher","first-page":"e900","DOI":"10.1371\/journal.pntd.0000900","volume":"4","author":"BJ Currie","year":"2010","unstructured":"Currie BJ, Ward L, Cheng AC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis. 2010;4(11):e900.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"2754_CR63","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/infdis\/168.5.1181","volume":"168","author":"W Chaowagul","year":"1993","unstructured":"Chaowagul W, et al. Relapse in melioidosis: incidence and risk factors. J Infect Dis. 1993;168(5):1181\u20135.","journal-title":"J Infect Dis"},{"key":"2754_CR64","unstructured":"CDC. Melioidosis and cases around the world. 2025 (cited 5 September 2025). https:\/\/www.cdc.gov\/melioidosis\/risk-factors\/index.html?utm_source=chatgpt.com."},{"issue":"6","key":"2754_CR65","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1111\/j.1365-2672.2007.03706.x","volume":"104","author":"E Mahenthiralingam","year":"2008","unstructured":"Mahenthiralingam E, Baldwin A, Dowson CG. Burkholderia cepacia complex bacteria: opportunistic pathogens with important natural biology. J Appl Microbiol. 2008;104(6):1539\u201351.","journal-title":"J Appl Microbiol"},{"key":"2754_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/1746-6148-7-4","volume":"7","author":"MC Elschner","year":"2011","unstructured":"Elschner MC, et al. Use of a Western blot technique for the serodiagnosis of glanders. BMC Vet Res. 2011;7:4.","journal-title":"BMC Vet Res"},{"key":"2754_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2021.628389","volume":"8","author":"MC Elschner","year":"2021","unstructured":"Elschner MC, et al. Validation of a commercial glanders ELISA as an alternative to the CFT in international trade of Equidae. Front Vet Sci. 2021;8:628389.","journal-title":"Front Vet Sci"},{"key":"2754_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jevs.2021.103403","volume":"99","author":"N Shakibamehr","year":"2021","unstructured":"Shakibamehr N, et al. Designing of Western blot technique for glanders diagnosing in Iran. J Equine Vet Sci. 2021;99:103403.","journal-title":"J Equine Vet Sci"},{"key":"2754_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2022.1056996","volume":"9","author":"H Brangsch","year":"2022","unstructured":"Brangsch H, et al. Sequence-based detection and typing procedures for Burkholderia mallei: assessment and prospects. Front Vet Sci. 2022;9:1056996.","journal-title":"Front Vet Sci"},{"issue":"1","key":"2754_CR70","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12866-021-02276-1","volume":"21","author":"W Watthanaworawit","year":"2021","unstructured":"Watthanaworawit W, et al. A multi-country study using MALDI-TOF mass spectrometry for rapid identification of Burkholderia pseudomallei. BMC Microbiol. 2021;21(1):213.","journal-title":"BMC Microbiol"},{"key":"2754_CR71","unstructured":"European Medicines Agency. Glanders and Melioidosis. 2002 (2 March 2025). https:\/\/www.ema.europa.eu\/en\/documents\/other\/pathogen-specific-database-glanders-and-melioidosis_en.pdf?utm_source=chatgpt.com."},{"key":"2754_CR72","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/1746-6148-8-214","volume":"8","author":"M Saqib","year":"2012","unstructured":"Saqib M, et al. Effectiveness of an antimicrobial treatment scheme in a confined glanders outbreak. BMC Vet Res. 2012;8:214.","journal-title":"BMC Vet Res"},{"key":"2754_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13110926","author":"FF Norman","year":"2024","unstructured":"Norman FF, et al. The evolving global epidemiology of human melioidosis: a narrative review. Pathogens. 2024. https:\/\/doi.org\/10.3390\/pathogens13110926.","journal-title":"Pathogens"},{"key":"2754_CR74","unstructured":"CDC. Melioidosis (Burkholderia pseudomallei) 2023 Case Definition. 2023 (5 September 2025). https:\/\/ndc.services.cdc.gov\/case-definitions\/melioidosis-burkholderia-pseudomallei-2023\/?utm_source=chatgpt.com."},{"issue":"1","key":"2754_CR75","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tim.2023.07.008","volume":"32","author":"ED Phillips","year":"2024","unstructured":"Phillips ED, Garcia EC. Burkholderia pseudomallei. Trends Microbiol. 2024;32(1):105\u20136.","journal-title":"Trends Microbiol"},{"issue":"3","key":"2754_CR76","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/QCO.0000000000000827","volume":"35","author":"E Birnie","year":"2022","unstructured":"Birnie E, Biemond JJ, Wiersinga WJ. Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change. Curr Opin Infect Dis. 2022;35(3):196\u2013204.","journal-title":"Curr Opin Infect Dis"},{"key":"2754_CR77","unstructured":"The Guardian. Two die in far north Queensland as health authorities warn of spike in melioidosis. 2025 (5 September 2025). https:\/\/www.theguardian.com\/australia-news\/2025\/feb\/14\/melioidosis-outbreak-queensland-death-toll-bacterial-infection?utm_source=chatgpt.com."},{"issue":"12","key":"2754_CR78","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.3201\/eid2712.211756","volume":"27","author":"P Dawson","year":"2021","unstructured":"Dawson P, et al. Human melioidosis caused by novel transmission of Burkholderia pseudomallei from freshwater home aquarium, United States(1). Emerg Infect Dis. 2021;27(12):3030\u20135.","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"2754_CR79","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa2116130","volume":"386","author":"JE Gee","year":"2022","unstructured":"Gee JE, et al. Multistate outbreak of melioidosis associated with imported aromatherapy spray. N Engl J Med. 2022;386(9):861\u20138.","journal-title":"N Engl J Med"},{"issue":"1","key":"2754_CR80","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1101\/gr.177543.114","volume":"25","author":"T Nandi","year":"2015","unstructured":"Nandi T, et al. Burkholderia pseudomallei sequencing identifies genomic clades with distinct recombination, accessory, and epigenetic profiles. Genome Res. 2015;25(1):129\u201341.","journal-title":"Genome Res"},{"issue":"4","key":"2754_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000845","volume":"6","author":"T Nandi","year":"2010","unstructured":"Nandi T, et al. A genomic survey of positive selection in Burkholderia pseudomallei provides insights into the evolution of accidental virulence. PLoS Pathog. 2010;6(4):e1000845.","journal-title":"PLoS Pathog"},{"key":"2754_CR82","doi-asserted-by":"publisher","first-page":"14240","DOI":"10.1073\/pnas.0403302101","volume":"101","author":"M Holden","year":"2004","unstructured":"Holden M, et al. From the cover: genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci USA. 2004;101:14240\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2754_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-9-190","volume":"9","author":"S Tumapa","year":"2008","unstructured":"Tumapa S, et al. Burkholderia pseudomallei genome plasticity associated with genomic island variation. BMC Genomics. 2008;9(1):190.","journal-title":"BMC Genomics"},{"key":"2754_CR84","doi-asserted-by":"publisher","first-page":"6865","DOI":"10.1128\/AEM.01036-06","volume":"72","author":"T Inglis","year":"2006","unstructured":"Inglis T, Sagripanti J-L. Environmental factors that affect the survival and persistence of Burkholderia pseudomallei. Appl Environ Microbiol. 2006;72:6865\u201375.","journal-title":"Appl Environ Microbiol"},{"key":"2754_CR85","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3389\/fmicb.2017.01353","volume":"8","author":"MR Mangalea","year":"2017","unstructured":"Mangalea MR, Plumley BA, Borlee BR. Nitrate sensing and metabolism inhibit biofilm formation in the opportunistic pathogen Burkholderia pseudomallei by reducing the intracellular concentration of c-di-GMP. Front Microbiol. 2017;8:1353.","journal-title":"Front Microbiol"},{"issue":"1","key":"2754_CR86","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2022.2139063","volume":"13","author":"NM Bzdyl","year":"2022","unstructured":"Bzdyl NM, et al. Pathogenicity and virulence of Burkholderia pseudomallei. Virulence. 2022;13(1):2139063.","journal-title":"Virulence"},{"issue":"1","key":"2754_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005241","volume":"11","author":"J Vadivelu","year":"2017","unstructured":"Vadivelu J, et al. Survival and intra-nuclear trafficking of Burkholderia pseudomallei: strategies of evasion from immune surveillance? PLoS Negl Trop Dis. 2017;11(1):e0005241.","journal-title":"PLoS Negl Trop Dis"},{"key":"2754_CR88","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fmicb.2011.00151","volume":"2","author":"B Adler","year":"2011","unstructured":"Adler B. Strategies for intracellular survival of Burkholderia pseudomallei. Front Microbiol. 2011;2:170.","journal-title":"Front Microbiol"},{"issue":"5","key":"2754_CR89","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00378-23","volume":"8","author":"JL Stockton","year":"2023","unstructured":"Stockton JL, et al. Burkholderia pseudomallei BicA protein promotes pathogenicity in macrophages by regulating invasion, intracellular survival, and virulence. mSphere. 2023;8(5):e0037823.","journal-title":"mSphere"},{"issue":"1","key":"2754_CR90","doi-asserted-by":"publisher","first-page":"24966","DOI":"10.1038\/s41598-024-74922-3","volume":"14","author":"CMS Cagape","year":"2024","unstructured":"Cagape CMS, et al. Genetic variation, structural analysis, and virulence implications of BimA and BimC in clinical isolates of Burkholderia pseudomallei in Thailand. Sci Rep. 2024;14(1):24966.","journal-title":"Sci Rep"},{"issue":"1","key":"2754_CR91","doi-asserted-by":"publisher","first-page":"16923","DOI":"10.1038\/s41598-020-73887-3","volume":"10","author":"BN Ross","year":"2020","unstructured":"Ross BN, et al. Predicting toxins found in toxin\u2013antitoxin systems with a role in host-induced Burkholderia pseudomallei persistence. Sci Rep. 2020;10(1):16923.","journal-title":"Sci Rep"},{"issue":"8","key":"2754_CR92","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00748-24","volume":"12","author":"I Chapartegui-Gonz\u00e1lez","year":"2024","unstructured":"Chapartegui-Gonz\u00e1lez I, et al. Unraveling the role of toxin-antitoxin systems in Burkholderia pseudomallei: exploring bacterial pathogenesis and interactions within the HigBA families. Microbiol Spectr. 2024;12(8):e0074824.","journal-title":"Microbiol Spectr"},{"issue":"7","key":"2754_CR93","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/s41579-019-0196-3","volume":"17","author":"NQ Balaban","year":"2019","unstructured":"Balaban NQ, et al. Definitions and guidelines for research on antibiotic persistence. Nat Rev Microbiol. 2019;17(7):441\u20138.","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"2754_CR94","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10541-005-0111-6","volume":"70","author":"K Lewis","year":"2005","unstructured":"Lewis K. Persister cells and the riddle of biofilm survival. Biochemistry Moscow. 2005;70(2):267\u201374.","journal-title":"Biochemistry Moscow"},{"issue":"5","key":"2754_CR95","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","volume":"14","author":"A Brauner","year":"2016","unstructured":"Brauner A, et al. Distinguishing between resistance, tolerance and persistence to antibiotic treatment. Nat Rev Microbiol. 2016;14(5):320\u201330.","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"2754_CR96","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1042\/BJ20140073","volume":"459","author":"A Butt","year":"2014","unstructured":"Butt A, et al. The hica toxin from Burkholderia pseudomallei has a role in persister cell formation. Biochem J. 2014;459(2):333\u201344.","journal-title":"Biochem J"},{"issue":"3","key":"2754_CR97","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1128\/iai.64.3.782-790.1996","volume":"64","author":"AL Jones","year":"1996","unstructured":"Jones AL, Beveridge TJ, Woods DE. Intracellular survival of Burkholderia pseudomallei. Infect Immun. 1996;64(3):782\u201390.","journal-title":"Infect Immun"},{"issue":"1","key":"2754_CR98","volume":"2018","author":"T Duangurai","year":"2018","unstructured":"Duangurai T, Indrawattana N, Pumirat P. Burkholderia pseudomallei adaptation for survival in stressful conditions. BioMed Res Int. 2018;2018(1):3039106.","journal-title":"BioMed Res Int"},{"key":"2754_CR99","doi-asserted-by":"publisher","first-page":"12958","DOI":"10.3389\/bjbs.2024.12958","volume":"81","author":"AP Kunnath","year":"2024","unstructured":"Kunnath AP, et al. Bacterial persister cells and development of antibiotic resistance in chronic infections: an update. Br J Biomed Sci. 2024;81:12958.","journal-title":"Br J Biomed Sci"},{"issue":"2","key":"2754_CR100","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/1348-0421.12762","volume":"64","author":"PS Ganesh","year":"2020","unstructured":"Ganesh PS, et al. Intracellular survival and innate immune evasion of Burkholderia cepacia: Improved understanding of quorum sensing-controlled virulence factors, biofilm, and inhibitors. Microbiol Immunol. 2020;64(2):87\u201398.","journal-title":"Microbiol Immunol"},{"issue":"1","key":"2754_CR101","doi-asserted-by":"publisher","first-page":"6","DOI":"10.7861\/clinmed.2022-0014","volume":"22","author":"P Karunanayake","year":"2022","unstructured":"Karunanayake P. Melioidosis: clinical aspects. Clin Med (Lond). 2022;22(1):6\u20138.","journal-title":"Clin Med (Lond)"},{"issue":"4","key":"2754_CR102","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/20009666.2017.1348875","volume":"7","author":"M Singh","year":"2017","unstructured":"Singh M, Mahmood M. Melioidosis: the great mimicker. J Community Hosp Intern Med Perspect. 2017;7(4):245\u20137.","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"978","key":"2754_CR103","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1259\/bjr\/15785231","volume":"82","author":"M Muttarak","year":"2009","unstructured":"Muttarak M, et al. Spectrum of imaging findings in melioidosis. Br J Radiol. 2009;82(978):514\u201321.","journal-title":"Br J Radiol"},{"key":"2754_CR104","doi-asserted-by":"publisher","first-page":"327","DOI":"10.31128\/AJGP-04-18-4558","volume":"48","author":"A Chakravorty","year":"2019","unstructured":"Chakravorty A, Heath C. Melioidosis: an updated review. Aust J Gen Pract. 2019;48:327\u201332.","journal-title":"Aust J Gen Pract"},{"issue":"9","key":"2754_CR105","volume":"16","author":"KG Narne","year":"2024","unstructured":"Narne KG, et al. Disseminated melioidosis complicated by prostatic abscess and splenic involvement: diagnostic and therapeutic insights. Cureus. 2024;16(9):e69961.","journal-title":"Cureus"},{"issue":"6","key":"2754_CR106","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1177\/1535370215583801","volume":"240","author":"SK Lau","year":"2015","unstructured":"Lau SK, et al. Laboratory diagnosis of melioidosis: past, present and future. Exp Biol Med (Maywood). 2015;240(6):742\u201351.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"7","key":"2754_CR107","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1128\/JCM.41.7.3312-3316.2003","volume":"41","author":"K Howard","year":"2003","unstructured":"Howard K, Inglis TJ. Novel selective medium for isolation of Burkholderia pseudomallei. J Clin Microbiol. 2003;41(7):3312\u20136.","journal-title":"J Clin Microbiol"},{"issue":"12","key":"2754_CR108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0013761","volume":"19","author":"I Gassiep","year":"2025","unstructured":"Gassiep I, et al. Laboratory diagnosis of melioidosis. PLoS Negl Trop Dis. 2025;19(12):e0013761.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"2754_CR109","doi-asserted-by":"crossref","first-page":"e141045","DOI":"10.3201\/eid2102.141045","volume":"21","author":"AR Hoffmaster","year":"2015","unstructured":"Hoffmaster AR, et al. Melioidosis diagnostic workshop, 2013. Emerg Infect Dis. 2015;21(2):e141045.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"2754_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/jgid.jgid_107_17","volume":"10","author":"N Ranjan","year":"2018","unstructured":"Ranjan N, Ranjan KP. State of the globe: melioidosis: diagnostic caveats and emerging solutions. J Glob Infect Dis. 2018;10(1):1\u20132.","journal-title":"J Glob Infect Dis"},{"issue":"1","key":"2754_CR111","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1186\/s12879-025-11214-9","volume":"25","author":"C Chen","year":"2025","unstructured":"Chen C, et al. Diagnostic accuracy of non-culture methods for the diagnosis of melioidosis: a systematic review and meta-analysis. BMC Infect Dis. 2025;25(1):851.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2754_CR112","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4103\/jgid.jgid_129_20","volume":"13","author":"VK Mohan","year":"2021","unstructured":"Mohan VK, et al. Unusual presentations of abdominal melioidosis. J Glob Infect Dis. 2021;13(1):52\u20135.","journal-title":"J Glob Infect Dis"},{"key":"2754_CR113","unstructured":"CDC. Clinical overview of melioidosis. 2024 (cited 2024 August). https:\/\/www.cdc.gov\/melioidosis\/hcp\/clinical-overview\/index.html"},{"issue":"1","key":"2754_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmicom.2024.100008","volume":"1","author":"EM Meumann","year":"2024","unstructured":"Meumann EM, Currie BJ. Approach to melioidosis. CMI Commun. 2024;1(1):100008.","journal-title":"CMI Commun"},{"issue":"6","key":"2754_CR115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011382","volume":"17","author":"T Anothaisintawee","year":"2023","unstructured":"Anothaisintawee T, et al. Efficacy of drug treatment for severe melioidosis and eradication treatment of melioidosis: a systematic review and network meta-analysis. PLoS Negl Trop Dis. 2023;17(6):e0011382.","journal-title":"PLoS Negl Trop Dis"},{"key":"2754_CR116","doi-asserted-by":"publisher","first-page":"1045088","DOI":"10.3389\/fvets.2022.1045088","volume":"9","author":"HS Jayasinghearachchi","year":"2022","unstructured":"Jayasinghearachchi HS, et al. Burkholderia pseudomallei in soil and natural water bodies in rural Sri Lanka: a hidden threat to public health. Front Vet Sci. 2022;9:1045088.","journal-title":"Front Vet Sci"},{"issue":"25","key":"2754_CR117","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1056\/NEJMoa2306448","volume":"389","author":"JK Petras","year":"2023","unstructured":"Petras JK, et al. Locally acquired melioidosis linked to environment\u2013Mississippi, 2020\u20132023. N Engl J Med. 2023;389(25):2355\u201362.","journal-title":"N Engl J Med"},{"key":"2754_CR118","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-3-031-24355-4_15","volume-title":"Vaccines for neglected pathogens: strategies, achievements and challenges: focus on leprosy, leishmaniasis, melioidosis and tuberculosis","author":"M Galeas-Pena","year":"2023","unstructured":"Galeas-Pena M, Morici LA. Vaccine development against melioidosis. In: Christodoulides M, editor. Vaccines for neglected pathogens: strategies, achievements and challenges: focus on leprosy, leishmaniasis, melioidosis and tuberculosis. Cham: Springer; 2023. p. 329\u201344."},{"key":"2754_CR119","doi-asserted-by":"publisher","first-page":"1582113","DOI":"10.3389\/fimmu.2025.1582113","volume":"16","author":"S Sengyee","year":"2025","unstructured":"Sengyee S, et al. Melioidosis vaccines: recent advances and future directions. Front Immunol. 2025;16:1582113.","journal-title":"Front Immunol"},{"issue":"1","key":"2754_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01246-2","volume":"10","author":"AJ Badten","year":"2025","unstructured":"Badten AJ, et al. Evaluation of highly conserved Burkholderia pseudomallei outer membrane proteins as protective antigens against respiratory melioidosis. NPJ Vacc. 2025;10(1):186.","journal-title":"NPJ Vacc"},{"issue":"4","key":"2754_CR121","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00186-24","volume":"15","author":"MV Tullius","year":"2024","unstructured":"Tullius MV, et al. LVS \u0394capB-vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB\/c mice. MBio. 2024;15(4):e0018624.","journal-title":"MBio"},{"key":"2754_CR122","doi-asserted-by":"publisher","DOI":"10.1128\/mSphere.00570-18","author":"N Khakhum","year":"2019","unstructured":"Khakhum N, et al. Burkholderia pseudomallei \u0394tonB \u0394hcp1 live attenuated vaccine strain elicits full protective immunity against aerosolized melioidosis infection. MSphere. 2019. https:\/\/doi.org\/10.1128\/mSphere.00570-18.","journal-title":"MSphere"},{"issue":"1","key":"2754_CR123","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2307503","volume":"56","author":"JC Guti\u00e9rrez Santana","year":"2024","unstructured":"Guti\u00e9rrez Santana JC, Coria Jim\u00e9nez VR. Burkholderia cepacia complex in cystic fibrosis: critical gaps in diagnosis and therapy. Ann Med. 2024;56(1):2307503.","journal-title":"Ann Med"},{"issue":"5","key":"2754_CR124","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3390\/pr13051270","volume":"13","author":"G Silva-Santana","year":"2025","unstructured":"Silva-Santana G, et al. Pharmaceutical contamination by biofilms formed of the Burkholderia cepacia complex: public health risks. Processes. 2025;13(5):1270.","journal-title":"Processes"},{"key":"2754_CR125","doi-asserted-by":"publisher","first-page":"1476041","DOI":"10.3389\/fmicb.2024.1476041","volume":"15","author":"JS Canning","year":"2024","unstructured":"Canning JS, et al. Phage therapy to treat cystic fibrosis Burkholderia cepacia complex lung infections: perspectives and challenges. Front Microbiol. 2024;15:1476041.","journal-title":"Front Microbiol"},{"key":"2754_CR126","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3389\/fmicb.2018.00383","volume":"9","author":"J Bodilis","year":"2018","unstructured":"Bodilis J, et al. Comparative genomics of environmental and clinical Burkholderia cenocepacia strains closely related to the highly transmissible epidemic ET12 lineage. Front Microbiol. 2018;9:383.","journal-title":"Front Microbiol"},{"issue":"1","key":"2754_CR127","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-6-66","volume":"6","author":"P Guglierame","year":"2006","unstructured":"Guglierame P, et al. Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome. BMC Microbiol. 2006;6(1):66.","journal-title":"BMC Microbiol"},{"key":"2754_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-9-200","volume":"9","author":"S Buroni","year":"2009","unstructured":"Buroni S, et al. Assessment of three resistance-nodulation-cell division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance. BMC Microbiol. 2009;9:200.","journal-title":"BMC Microbiol"},{"issue":"4","key":"2754_CR129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094372","volume":"9","author":"B Cuzzi","year":"2014","unstructured":"Cuzzi B, et al. Versatility of the Burkholderia cepacia complex for the biosynthesis of exopolysaccharides: a comparative structural investigation. PLoS ONE. 2014;9(4):e94372.","journal-title":"PLoS ONE"},{"issue":"1","key":"2754_CR130","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-4-8","volume":"4","author":"JF Chmiel","year":"2003","unstructured":"Chmiel JF, Davis PB. State of the art: why do the lungs of patients with cystic fibrosis become infected and why can\u2019t they clear the infection? Respir Res. 2003;4(1):8.","journal-title":"Respir Res"},{"issue":"5","key":"2754_CR131","doi-asserted-by":"publisher","first-page":"400","DOI":"10.4161\/viru.25338","volume":"4","author":"A Suppiger","year":"2013","unstructured":"Suppiger A, et al. Two quorum sensing systems control biofilm formation and virulence in members of the Burkholderia cepacia complex. Virulence. 2013;4(5):400\u20139.","journal-title":"Virulence"},{"issue":"1","key":"2754_CR132","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-10-441","volume":"10","author":"EP O'Grady","year":"2009","unstructured":"O\u2019Grady EP, et al. Reciprocal regulation by the CepIR and CciIR quorum sensing systems in Burkholderia cenocepacia. BMC Genomics. 2009;10(1):441.","journal-title":"BMC Genomics"},{"issue":"9","key":"2754_CR133","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1139\/cjm-2015-0316","volume":"61","author":"MA Valvano","year":"2015","unstructured":"Valvano MA. Intracellular survival of Burkholderia cepacia complex in phagocytic cells. Can J Microbiol. 2015;61(9):607\u201315.","journal-title":"Can J Microbiol"},{"issue":"4","key":"2754_CR134","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s42770-021-00564-6","volume":"52","author":"PHR da Silva","year":"2021","unstructured":"da Silva PHR, et al. Biofilm formation by strains of Burkholderia cenocepacia lineages IIIA and IIIB and B. gladioli pv. alliicola associated with onion bacterial scale rot. Braz J Microbiol. 2021;52(4):1665\u201375.","journal-title":"Braz J Microbiol"},{"key":"2754_CR135","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/607575","author":"SA Sousa","year":"2011","unstructured":"Sousa SA, Ramos CG, Leit\u00e3o JH. Burkholderia cepacia complex: emerging multihost pathogens equipped with a wide range of virulence factors and determinants. Int J Microbiol. 2011. https:\/\/doi.org\/10.1155\/2011\/607575.","journal-title":"Int J Microbiol"},{"key":"2754_CR136","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/IDR.S68214","volume":"8","author":"JG Malone","year":"2015","unstructured":"Malone JG. Role of small colony variants in persistence of Pseudomonas aeruginosa infections in cystic fibrosis lungs. Infect Drug Resist. 2015;8:237\u201347.","journal-title":"Infect Drug Resist"},{"issue":"6","key":"2754_CR137","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1080\/21505594.2016.1237334","volume":"8","author":"AS Moreira","year":"2017","unstructured":"Moreira AS, et al. Variation of Burkholderia cenocepacia virulence potential during cystic fibrosis chronic lung infection. Virulence. 2017;8(6):782\u201396.","journal-title":"Virulence"},{"key":"2754_CR138","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2011.00012","volume":"1","author":"CP Coutinho","year":"2011","unstructured":"Coutinho CP. Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations. Front Cell Infect Microbiol. 2011;1:12.","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"2754_CR139","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.micpath.2010.08.003","volume":"49","author":"T Mullen","year":"2010","unstructured":"Mullen T, Callaghan M, McClean S. Invasion of Burkholderia cepacia complex isolates into lung epithelial cells involves glycolipid receptors. Microb Pathog. 2010;49(6):381\u20137.","journal-title":"Microb Pathog"},{"issue":"24","key":"2754_CR140","doi-asserted-by":"publisher","first-page":"8247","DOI":"10.1128\/JB.187.24.8247-8255.2005","volume":"187","author":"S Gingues","year":"2005","unstructured":"Gingues S, et al. Distribution and expression of the ZmpA metalloprotease in the Burkholderia cepacia complex. J Bacteriol. 2005;187(24):8247\u201355.","journal-title":"J Bacteriol"},{"issue":"7","key":"2754_CR141","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1128\/IAI.00297-06","volume":"74","author":"C Kooi","year":"2006","unstructured":"Kooi C, et al. Burkholderia cenocepacia ZmpB is a broad-specificity zinc metalloprotease involved in virulence. Infect Immun. 2006;74(7):4083\u201393.","journal-title":"Infect Immun"},{"issue":"5","key":"2754_CR142","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1002\/ppul.26359","volume":"58","author":"V Dacc\u00f2","year":"2023","unstructured":"Dacc\u00f2 V, et al. Cepacia syndrome in cystic fibrosis: a systematic review of the literature and possible new perspectives in treatment. Pediatr Pulmonol. 2023;58(5):1337\u201343.","journal-title":"Pediatr Pulmonol"},{"key":"2754_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijregi.2024.03.010","volume":"11","author":"T Ibrahim","year":"2024","unstructured":"Ibrahim T, et al. Epidemiology, microbiological, clinical characteristics, and outcome of Burkholderia cepacia complex infections in non-cystic fibrosis adult patients from Qatar. IJID Reg. 2024;11:100355.","journal-title":"IJID Reg"},{"issue":"10","key":"2754_CR144","volume":"16","author":"P Periaiah","year":"2024","unstructured":"Periaiah P, Antony T, Samuel S. Identification of Burkholderia cepacia complex: comparing conventional, automated, and molecular methods in a tertiary care center. Cureus. 2024;16(10):e70847.","journal-title":"Cureus"},{"issue":"10","key":"2754_CR145","doi-asserted-by":"publisher","first-page":"e00961","DOI":"10.1128\/jcm.00961-24","volume":"62","author":"S Campbell","year":"2024","unstructured":"Campbell S, et al. Performance of MALDI-TOF MS, real-time PCR, antigen detection, and automated biochemical testing for the identification of Burkholderia pseudomallei. J Clin Microbiol. 2024;62(10):e00961-e1024.","journal-title":"J Clin Microbiol"},{"issue":"5","key":"2754_CR146","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ijantimicag.2008.09.010","volume":"33","author":"SG Avgeri","year":"2009","unstructured":"Avgeri SG, et al. Therapeutic options for Burkholderia cepacia infections beyond co-trimoxazole: a systematic review of the clinical evidence. Int J Antimicrob Agents. 2009;33(5):394\u2013404.","journal-title":"Int J Antimicrob Agents"},{"key":"2754_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2025.101601","volume":"66","author":"AR Zomorodi","year":"2025","unstructured":"Zomorodi AR, et al. In vitro susceptibility of Burkholderia cepacia to ceftazidime-avibactam: a systematic review. New Microbes New Infect. 2025;66:101601.","journal-title":"New Microbes New Infect"},{"issue":"3","key":"2754_CR148","doi-asserted-by":"publisher","first-page":"00055","DOI":"10.1183\/23120541.00055-2023","volume":"9","author":"AM Akkerman-Nijland","year":"2023","unstructured":"Akkerman-Nijland AM, et al. Eradication of Burkholderia cepacia complex in cystic fibrosis patients with inhalation of amiloride and tobramycin combined with oral cotrimoxazole. ERJ Open Res. 2023;9(3):00055\u20132023.","journal-title":"ERJ Open Res"},{"key":"2754_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2024.e02081","volume":"38","author":"Y Suzuki","year":"2024","unstructured":"Suzuki Y, et al. Efficacy of combination antibiotic therapy including inhaled tobramycin on Burkholderia cepacia pneumonia in a non-cystic fibrosis patient. IDCases. 2024;38:e02081.","journal-title":"IDCases"},{"issue":"1","key":"2754_CR150","volume":"10","author":"N Cassir","year":"2025","unstructured":"Cassir N, et al. Multi-target combination of antibiotics as salvage therapy for severe infection caused by pan-resistant Burkholderia cenocepacia following lung transplantation. Transplant Rep. 2025;10(1):100170.","journal-title":"Transplant Rep"},{"issue":"1","key":"2754_CR151","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1513\/AnnalsATS.201408-395OC","volume":"12","author":"JE Zlosnik","year":"2015","unstructured":"Zlosnik JE, et al. Burkholderia species infections in patients with cystic fibrosis in British Columbia, Canada. 30 years\u2019 experience. Ann Am Thorac Soc. 2015;12(1):70\u20138.","journal-title":"Ann Am Thorac Soc"},{"key":"2754_CR152","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fcimb.2011.00018","volume":"1","author":"A Horsley","year":"2011","unstructured":"Horsley A, et al. Can early Burkholderia cepacia complex infection in cystic fibrosis be eradicated with antibiotic therapy? Front Cell Infect Microbiol. 2011;1:18.","journal-title":"Front Cell Infect Microbiol"},{"issue":"7","key":"2754_CR153","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1128\/JCM.42.7.3052-3058.2004","volume":"42","author":"MV Cunha","year":"2004","unstructured":"Cunha MV, et al. Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections. J Clin Microbiol. 2004;42(7):3052\u20138.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2754_CR154","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1462-5822.2006.00766.x","volume":"9","author":"J Lamothe","year":"2007","unstructured":"Lamothe J, et al. Intracellular survival of Burkholderia cenocepacia in macrophages is associated with a delay in the maturation of bacteria-containing vacuoles. Cell Microbiol. 2007;9(1):40\u201353.","journal-title":"Cell Microbiol"},{"issue":"Pt 9","key":"2754_CR155","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1099\/mic.0.031344-0","volume":"155","author":"MS Sald\u00edas","year":"2009","unstructured":"Sald\u00edas MS, Valvano MA. Interactions of Burkholderia cenocepacia and other Burkholderia cepacia complex bacteria with epithelial and phagocytic cells. Microbiology (Reading, Engl). 2009;155(Pt 9):2809\u201317.","journal-title":"Microbiology (Reading, Engl)"},{"key":"2754_CR156","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00029-16","author":"IN Silva","year":"2016","unstructured":"Silva IN, et al. Long-term evolution of Burkholderia multivorans during a chronic cystic fibrosis infection reveals shifting forces of selection. mSystems. 2016. https:\/\/doi.org\/10.1128\/mSystems.00029-16.","journal-title":"mSystems"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02754-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-02754-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-02754-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:48:58Z","timestamp":1782906538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-026-02754-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,22]]},"references-count":156,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2754"],"URL":"https:\/\/doi.org\/10.1007\/s15010-026-02754-6","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,22]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests to be disclosed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declared no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}